ADMA Biologics, Inc. (ADMA)
9.72
-0.21
(-2.11%)
USD |
NASDAQ |
Oct 02, 16:00
9.72
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Profit Margin (Quarterly) : 30.40% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.40% |
| March 31, 2026 | 39.59% |
| December 31, 2025 | 35.48% |
| September 30, 2025 | 27.14% |
| June 30, 2025 | 28.05% |
| March 31, 2025 | 23.44% |
| December 31, 2024 | 95.19% |
| September 30, 2024 | 29.96% |
| June 30, 2024 | 29.91% |
| March 31, 2024 | 21.75% |
| December 31, 2023 | -23.88% |
| September 30, 2023 | 3.81% |
| June 30, 2023 | -10.60% |
| March 31, 2023 | -11.93% |
| December 31, 2022 | -24.47% |
| September 30, 2022 | -36.26% |
| June 30, 2022 | -40.60% |
| March 31, 2022 | -85.93% |
| December 31, 2021 | -63.11% |
| September 30, 2021 | -85.65% |
| June 30, 2021 | -106.0% |
| March 31, 2021 | -114.5% |
| December 31, 2020 | -139.1% |
| September 30, 2020 | -164.6% |
| June 30, 2020 | -259.1% |
| Date | Value |
|---|---|
| March 31, 2020 | -188.7% |
| December 31, 2019 | -87.74% |
| September 30, 2019 | -158.4% |
| June 30, 2019 | -201.4% |
| March 31, 2019 | -370.3% |
| December 31, 2018 | -444.7% |
| September 30, 2018 | -357.8% |
| June 30, 2018 | -316.7% |
| March 31, 2018 | -440.9% |
| December 31, 2017 | -108.2% |
| September 30, 2017 | -321.5% |
| June 30, 2017 | -265.8% |
| March 31, 2017 | -248.7% |
| December 31, 2016 | -137.0% |
| September 30, 2016 | -147.4% |
| June 30, 2016 | -264.7% |
| March 31, 2016 | -217.2% |
| December 31, 2015 | -182.4% |
| September 30, 2015 | -275.4% |
| June 30, 2015 | -357.2% |
| March 31, 2015 | -239.9% |
| December 31, 2014 | -239.4% |
| September 30, 2014 | -247.8% |
| June 30, 2014 | -264.0% |
| March 31, 2014 | -378.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vericel Corp. | 2.85% |
| BioMarin Pharmaceutical, Inc. | 4.49% |
| Emergent BioSolutions, Inc. | -76.91% |
| Exelixis, Inc. | 33.73% |
| Akebia Therapeutics, Inc. | -18.13% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 40.13% |
| Return on Assets | 27.17% |
| Return on Invested Capital | 30.60% |
| Gross Profit Margin (Quarterly) | 69.31% |
| Operating Margin (Quarterly) | 42.16% |
| Return on Net Operating Assets | 39.86% |